Paper21397026
Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I.
Wolf DA and 7 others. Neurobiol Dis, 2011. Cited by 65 papers, by iCite.
Cite this record
ConductScience Library. Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I. Papers, record 21397026. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21397026
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Therapy | Major topic |
| Iduronidase | Major topic |
| Mucopolysaccharidosis I | Major topic |
| Transduction, Genetic | Major topic |
| Adenoviridae | |
| Animals | |
| Animals, Newborn | |
| Disease Models, Animal | |
| Female | |
| Humans | |
| Infusions, Intraventricular | |
| Male | |
| Mice | |
| Mice, Mutant Strains | |
| Up-Regulation |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 HD032652 | NICHD NIH HHS | United States | P01HD032652 | PubMed and NIH | NIH RePORTER |
| T32 DA022616 | NIDA NIH HHS | United States | T32DA022616 | PubMed and NIH | NIH RePORTER |
| P01HD032652 | NICHD NIH HHS | United States | P01HD032652 | PubMed and NIH | NIH RePORTER |
| T32 DA022616-01 | NIDA NIH HHS | United States | T32DA022616 | PubMed and NIH | NIH RePORTER |
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10051635 | Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10051635 | PubMed |
| 2 | 17519893 | Correction of clinical manifestations of canine mucopolysaccharidosis I with neonatal retroviral vector gene therapy. | Mol Ther | 2007 | https://conductscience.org/library/papers/17519893 | PubMed |
| 3 | 8213840 | Identification of mutations in the alpha-L-iduronidase gene (IDUA) that cause Hurler and Scheie syndromes. | Am J Hum Genet | 1993 | https://conductscience.org/library/papers/8213840 | PubMed |
| 4 | 3041032 | A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. | J Virol | 1987 | https://conductscience.org/library/papers/3041032 | PubMed |
| 5 | 15558784 | Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. | J Comp Neurol | 2004 | https://conductscience.org/library/papers/15558784 | PubMed |
| 6 | 10480370 | The frequency of lysosomal storage diseases in The Netherlands. | Hum Genet | 1999 | https://conductscience.org/library/papers/10480370 | PubMed |
| 7 | 16221840 | Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors. | J Neurosci | 2005 | https://conductscience.org/library/papers/16221840 | PubMed |
| 8 | 8058211 | Cerebellar contributions to instrumental learning. | Neurosci Biobehav Rev | 1994 | https://conductscience.org/library/papers/8058211 | PubMed |
| 9 | 16414198 | Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. | Neuroscience | 2006 | https://conductscience.org/library/papers/16414198 | PubMed |
| 10 | 21139569 | Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes. | Mol Ther | 2011 | https://conductscience.org/library/papers/21139569 | PubMed |
| 11 | 8704199 | Humoral immune response limits gene therapy in canine MPS I. | Blood | 1996 | https://conductscience.org/library/papers/8704199 | PubMed |
| 12 | 9523395 | Neonatal immunology. | Semin Perinatol | 1998 | https://conductscience.org/library/papers/9523395 | PubMed |
| 13 | 15229474 | Neonatal adaptive immunity comes of age. | Nat Rev Immunol | 2004 | https://conductscience.org/library/papers/15229474 | PubMed |
| 14 | 19098898 | Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. | Nat Biotechnol | 2009 | https://conductscience.org/library/papers/19098898 | PubMed |
| 15 | 438323 | Excretion-reuptake route of beta-hexosaminidase in normal and I-cell disease cultured fibroblasts. | J Clin Invest | 1979 | https://conductscience.org/library/papers/438323 | PubMed |
| 16 | 17180118 | Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector. | Mol Ther | 2007 | https://conductscience.org/library/papers/17180118 | PubMed |
| 17 | 11273777 | Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII. | Mol Ther | 2001 | https://conductscience.org/library/papers/11273777 | PubMed |
| 18 | 9672523 | Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. | J Pediatr | 1998 | https://conductscience.org/library/papers/9672523 | PubMed |
| 19 | 9749724 | Comparing the effects of selective cingulate cortex lesions and cingulum bundle lesions on water maze performance by rats. | Eur J Neurosci | 1998 | https://conductscience.org/library/papers/9749724 | PubMed |
| 20 | 18037941 | Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome. | Bone Marrow Transplant | 2008 | https://conductscience.org/library/papers/18037941 | PubMed |
Cited by49
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39687731 | Intrathecal or intravenous AAV9-IDUA/RGX-111 at minimal effective dose prevents cardiac, skeletal and neurologic manifestations of murine MPS I. | Mol Ther Methods Clin Dev | 2024 | https://conductscience.org/library/papers/39687731 | PubMed |
| 38906479 | Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications. | Adv Drug Deliv Rev | 2024 | https://conductscience.org/library/papers/38906479 | PubMed |
| 38397051 | Efficacy of a Combination Therapy with Laronidase and Genistein in Treating Mucopolysaccharidosis Type I in a Mouse Model. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38397051 | PubMed |
| 37543633 | Mapping brain networks in MPS I mice and their restoration following gene therapy. | Sci Rep | 2023 | https://conductscience.org/library/papers/37543633 | PubMed |
| 36704405 | Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of Hunter syndrome. | Mol Genet Metab Rep | 2023 | https://conductscience.org/library/papers/36704405 | PubMed |
| 36541357 | Neurologic Recovery in MPS I and MPS II Mice by AAV9-Mediated Gene Transfer to the CNS After the Development of Cognitive Dysfunction. | Hum Gene Ther | 2023 | https://conductscience.org/library/papers/36541357 | PubMed |
| 36457248 | Targeting the central nervous system in lysosomal storage diseases: Strategies to deliver therapeutics across the blood-brain barrier. | Mol Ther | 2023 | https://conductscience.org/library/papers/36457248 | PubMed |
| 36385771 | Routes of administration for adeno-associated viruses carrying gene therapies for brain diseases. | Front Mol Neurosci | 2022 | https://conductscience.org/library/papers/36385771 | PubMed |
| 36226412 | Phenotypic Correction of Murine Mucopolysaccharidosis Type II by Engraftment of Ex Vivo Lentiviral Vector-Transduced Hematopoietic Stem and Progenitor Cells. | Hum Gene Ther | 2022 | https://conductscience.org/library/papers/36226412 | PubMed |
| 36172050 | Delivering gene therapy for mucopolysaccharide diseases. | Front Mol Biosci | 2022 | https://conductscience.org/library/papers/36172050 | PubMed |
| 35573046 | Liver-directed gene therapy corrects neurologic disease in a murine model of mucopolysaccharidosis type I-Hurler. | Mol Ther Methods Clin Dev | 2022 | https://conductscience.org/library/papers/35573046 | PubMed |
| 35534672 | Improving Gene Therapy for Angelman Syndrome with Secreted Human UBE3A. | Neurotherapeutics | 2022 | https://conductscience.org/library/papers/35534672 | PubMed |
| 34502108 | Gene Therapy for Neuronopathic Mucopolysaccharidoses: State of the Art. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34502108 | PubMed |
| 34189746 | Mucopolysaccharidoses type I gene therapy. | J Inherit Metab Dis | 2021 | https://conductscience.org/library/papers/34189746 | PubMed |
| 34040503 | Comparative Effectiveness of Intracerebroventricular, Intrathecal, and Intranasal Routes of AAV9 Vector Administration for Genetic Therapy of Neurologic Disease in Murine Mucopolysaccharidosis Type I. | Front Mol Neurosci | 2021 | https://conductscience.org/library/papers/34040503 | PubMed |
| 33924076 | Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development. | Biomolecules | 2021 | https://conductscience.org/library/papers/33924076 | PubMed |
| 33572941 | Mucopolysaccharidosis Type I: Current Treatments, Limitations, and Prospects for Improvement. | Biomolecules | 2021 | https://conductscience.org/library/papers/33572941 | PubMed |
| 32461912 | Intravenous delivery for treatment of mucopolysaccharidosis type I: A comparison of AAV serotypes 9 and rh10. | Mol Genet Metab Rep | 2020 | https://conductscience.org/library/papers/32461912 | PubMed |
| 32201668 | A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management. | Intractable Rare Dis Res | 2020 | https://conductscience.org/library/papers/32201668 | PubMed |
| 30844402 | Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality. | Neuron | 2019 | https://conductscience.org/library/papers/30844402 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IDUA | 3425 | PubTator's text mining | https://conductscience.org/library/genes/3425 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21397026
GET https://conductscience.org/api/papers/v1/21397026/references?page=2